{"id":8325,"date":"2021-02-18T07:00:00","date_gmt":"2021-02-18T07:00:00","guid":{"rendered":"https:\/\/www.acarix.com\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/"},"modified":"2024-11-18T19:05:42","modified_gmt":"2024-11-18T19:05:42","slug":"acarix-ab-publ-publicerar-bokslutskommunike-2020-2","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/","title":{"rendered":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<div>\n<p class=\"mfn-wp-retain\">Press release (MAR)<\/p>\n<p class=\"mfn-wp-retain\">Malm&ouml;, 18 februari, 2021<\/p>\n<p class=\"mfn-wp-retain\"><strong>Acarix AB (publ) publicerar Bokslutskommunik&eacute; 2020<\/strong><\/p>\n<p class=\"mfn-wp-retain\"><strong>Ett starkt avslut p&aring; ett h&auml;ndelserikt &aring;r<\/strong><\/p>\n<p class=\"mfn-wp-retain\">Det fj&auml;rde kvartalet bidrog starkt till v&aring;r utveckling under 2020, med marknadsgodk&auml;nnandet f&ouml;r CADScor&reg; fr&aring;n det amerikanska l&auml;kemedelsverket US Food and Drug Administration (FDA), som kronan p&aring; verket.<\/p>\n<p class=\"mfn-wp-retain\"><em>Utdrag ur VD Per Perssons kommentar till del&aring;rsrapporten.<\/em><\/p>\n<p class=\"mfn-wp-retain\"><strong>Fj&auml;rde kvartalet 2020 j&auml;mf&ouml;rt med samma period 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under fj&auml;rde kvartalet s&aring;ldes 22 (10, varav 4 till kliniska pr&ouml;vningar) CADScor&reg;System och 1&nbsp;420 (1&nbsp;500, varav 840 till kliniska pr&ouml;vningar) eng&aring;ngspl&aring;ster till b&aring;de slutf&ouml;rbrukare och distribut&ouml;rer.<\/li>\n<li>Int&auml;kterna uppgick till 966 kSEK (774), med ett bruttoresultat om 713 kSEK (607) och en bruttomarginal om 74 procent (78).<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 12&nbsp;100 kSEK (10&nbsp;591).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till &ndash;11&nbsp;411 kSEK (&ndash;9&nbsp;987).<\/li>\n<li>Kassafl&ouml;det fr&aring;n den l&ouml;pande verksamheten uppgick till &ndash;12&nbsp;546 kSEK (&ndash;8&nbsp;122). Periodens nettokassafl&ouml;de uppgick till &ndash;12&nbsp;034 (26&nbsp;037) kSEK.<\/li>\n<li>Resultat per aktie uppgick till &ndash;0,08 SEK (&ndash;0,31). Inga utsp&auml;dningseffekter uppkom.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>R&auml;kenskaps&aring;ret 2020 j&auml;mf&ouml;rt med 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under &aring;ret s&aring;ldes totalt 51 (23, varav 5 till kliniska pr&ouml;vningar) CADScor&reg;System, och 3&nbsp;540 (4&nbsp;326, varav 2&nbsp;040 till kliniska pr&ouml;vningar) eng&aring;ngspl&aring;ster. Totalt f&ouml;r &aring;ret genererades int&auml;kter p&aring; 2&nbsp;170 kSEK (1&nbsp;857) med ett brutto-resultat om 1&nbsp;594 kSEK (1&nbsp;430), motsvarande en brutto-marginal p&aring; 73 procent (77).<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 43&nbsp;025 kSEK (47&nbsp;873).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till &ndash;41&nbsp;496 kSEK (&ndash;46&nbsp;434).<\/li>\n<li>Kassafl&ouml;det fr&aring;n den l&ouml;pande verksamheten uppgick till &ndash;36&nbsp;686 kSEK (&ndash;44&nbsp;533). Periodens nettokassafl&ouml;de till 10&nbsp;663 kSEK (&ndash;11&nbsp;500).<\/li>\n<li>Beh&aring;llning av likvida medel uppgick till 64&nbsp;113 kSEK (53&nbsp;747).<\/li>\n<li>Resultat per aktie uppgick till &ndash;0,51 SEK (&ndash;1,83). Inga utsp&auml;dningseffekter uppkom.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser under fj&auml;rde kvartalet 2020<\/strong><\/p>\n<ul type=\"disc\">\n<li>Den 15 oktober har bolaget ing&aring;tt avtal med Redeye AB avseende tj&auml;nsten som Certified Adviser. Redeye AB tilltr&auml;dde som Certified Adviser den 19 oktober 2020<\/li>\n<li>Den 18 november meddelade Acarix att bolagets analys av reell anv&auml;ndning av CADScor&reg;System, gjord i samarbete med kliniker i Tyskland och &Ouml;sterrike, presenteras som en poster p&aring; ISPOR, den ledande europeiska konferensen f&ouml;r h&auml;lsoekonomi och utfallsforskning, som h&aring;lls virtuellt den 16-19 november 2020.Analysen av patientdata visar att varken patientdemografi eller testresultat skiljer sig n&auml;mnv&auml;rt fr&aring;n de studiebaserade resultaten fr&aring;n DanNICAD&nbsp;1 och att verkliga data d&auml;rmed kan anv&auml;ndas f&ouml;r ytterligare ekonomisk modellering.<\/li>\n<li>Den 25 november meddelande bolaget att det amerikanska l&auml;kemedelsverket (FDA) har godk&auml;nt bolagets De Novo ans&ouml;kan f&ouml;r ett marknadsf&ouml;ringsgodk&auml;nnande f&ouml;r CADScor&reg;System i USA. &rdquo;Detta &auml;r en fenomenal prestation och ett enormt erk&auml;nnande av v&aring;r teknologi och CADScor&reg;Systems m&ouml;jlighet att f&ouml;rb&auml;ttra den diagnostiska processen f&ouml;r potentiella CAD-patienter i USA.&rdquo; s&auml;ger Per Persson, vd f&ouml;r Acarix.<\/li>\n<li>Den 9 december meddelade bolaget att den sista patienten har inkluderats i Dan-NICAD II studien. Dan-NICAD&nbsp;II studien som omfattar data fr&aring;n sammanlagt 1&nbsp;726 patienter inleddes i januari 2018 med syfte att ytterligare bef&auml;sta den diagnostiska noggrannheten f&ouml;r CADScor&reg;Systemet j&auml;mf&ouml;rt med andra stratifieringsalternativ tillg&auml;ngliga idag. Dan-NICAD&nbsp;II studien har &auml;ven omfattat patienter p&aring; under 40 &aring;r, vilket &ouml;ppnar upp f&ouml;r en m&ouml;jlig breddning av den idag g&auml;llande patientgruppen och som i slut&auml;ndan skulle kunna inneb&auml;ra att CADScor&reg;System kan anv&auml;ndas p&aring; patienter vid 30 &aring;rs &aring;lder.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser efter den 31 december 2020<\/strong><br \/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&middot;Den 13 januari meddelade bolaget positiva prelimin&auml;ra data fr&aring;n den unders&ouml;kande SEISMO-studien som g&ouml;rs med modifierade CADScor&reg;System f&ouml;r en potentiell hj&auml;rtsviktstill&auml;mpning. SEISMO-studien inleddes i juni 2018 f&ouml;r att utv&auml;rdera m&ouml;jligheten att utveckla en algoritm som kan skilja patienter som h&auml;nvisas med misstankar om hj&auml;rtsvikt. Studien, med totalt 199 patienter p&aring; tv&aring; platser i Danmark, inkluderade den sista patienten 2020. &rdquo;Att slutf&ouml;ra inkluderingen i den unders&ouml;kande hj&auml;rtsviktstudien var en stor milstolpe f&ouml;r alla inblandade. Dessa nya data ser lovande ut f&ouml;r att tidigt kunna utesluta hj&auml;rtsvikt och kommer att vara viktiga f&ouml;r alla drabbade patienter som idag v&auml;ntar alltf&ouml;r l&auml;nge p&aring; en slutlig diagnos. Dessa prelimin&auml;ra data kan motivera en uppf&ouml;ljningsstudie f&ouml;r att konsolidera resultaten och f&aring; mer data f&ouml;r algoritmutveckling&rdquo;, s&auml;ger professor Peter S&oslash;gaard, l&auml;kare och huvudpr&ouml;vare. Resultaten fr&aring;n den slutliga analysen av studiedata f&ouml;rv&auml;ntas l&auml;mnas f&ouml;r publicering under andra kvartalet 2021.<\/p>\n<p class=\"mfn-wp-retain\">Den fullst&auml;ndiga del&aring;rsrapporten finns tillg&auml;nglig via l&auml;nk nedan samt p&aring; www.acarix.com<\/p>\n<p class=\"mfn-wp-retain\"><strong>Kontaktpersoner f&ouml;r mer information <\/strong><\/p>\n<p class=\"mfn-wp-retain\">Per Persson, VD <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f9VxRezwN7-LLlLSjqkbNX5YErittpxuqSPpM0tvDGwp2j9G0STb2FI_Az7cylv0qI71He9kbHIuyOPU-V9BRtGW1danWAJrPkMcbJyL2BE=\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>per.persson@acarix.com<\/u><\/a> <br \/>+46 736 005&nbsp;990<\/p>\n<p class=\"mfn-wp-retain\">Christian Lindholm, CFO <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0yNnAwLb8gC_g6hFf81bT6sjaiICZahuFtC0j6M4Jn_n5LSsJlTWSgj-XDtdZYJts3YHpAvFjHpSO4GKvqx4xA1uIhPajDUL0cT3ZqumGCD18XgCiZLRCXfbt523H5rp\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>christian.lindholm@acarix.com<\/u><\/a><br \/>+46 705 118&nbsp;333<\/p>\n<p class=\"mfn-wp-retain\"><strong>Om Acarix<\/strong><br \/>Acarix grundades 2009 och &auml;r noterat p&aring; Nasdaq First North Premier. Acarix CADScor&reg;System anv&auml;nder en avancerad sensor som placeras p&aring; huden ovanf&ouml;r hj&auml;rtat f&ouml;r att lyssna p&aring; ljudet av hj&auml;rtkontraktion och turbulent fl&ouml;de. Det har utformats f&ouml;r att vara ett allt-i-ett-system i den meningen att signalen fr&aring;n hj&auml;rtat spelas in, bearbetas och visas som en patientspecifik s.k. CAD-score p&aring; sk&auml;rmen. Presentation av m&auml;tresultaten erh&aring;lls p&aring; mindre &auml;n 8 minuter. Som en s&auml;ker metod och l&auml;mplig f&ouml;r anv&auml;ndning i b&aring;de prim&auml;rv&aring;rden och p&aring; inneliggande patienter kan CADScor&reg;System potentiellt komma att spela en viktig roll f&ouml;r patient-triage, n&aring;got som g&ouml;r att m&aring;nga patienter inte beh&ouml;ver unders&ouml;kas ytterligare med invasiva, diagnostiska metoder. <br \/> Redeye AB &auml;r bolagets Certified Advisor (+46 (0)8 121 576 90, (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=71VkLZNGSaWoUwPLEkPRcNxjVzpAmhSkdjdE_Dhbm9RsUF_P5EZmu5ZCrfdf6WYOw71_HrImo9xY39WpaDZ82_oKqXiL6FANN1A5gpVvv4IVcSKjBU3gaUD_M6PuJ04N\" target=\"_blank\" rel=\"nofollow noopener\">certifiedadviser@redeye.se<\/a>). <br \/> F&ouml;r mer information bes&ouml;k www.acarix.com.<\/p>\n<p class=\"mfn-wp-retain\"><em>Denna <\/em><em>information <\/em><em>&auml;r regulatorisk information som Acarix AB (publ)<\/em> <em>ska offentligg&ouml;ra enligt EU:s marknadsmissbruksf&ouml;rordning.<\/em> <em>Informationen l&auml;mnades f&ouml;r publicering genom ovanst&aring;ende kontaktpersons f&ouml;rsorg den 18 februari 2021 kl 08.00.<\/em><\/p>\n<p class=\"mfn-wp-retain\">\n<p><\/div>\n<div class=\"mfn-footer mfn-attachment\">\n<p class=\"mfn-wp-retain\"><strong>Bifogade filer<\/strong><\/p>\n<hr>\n<p class=\"mfn-wp-retain\"><a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/c77fe4ab-71c1-4fcd-b27d-f39b58cf815c\" target=\"_blank\" rel=\"nofollow noopener\">Acarix Bokslutskommunike Q4 2020_Final<\/a><br \/><a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/f88e5430-7ea2-4ba1-ae66-bba89f821649\" target=\"_blank\" rel=\"nofollow noopener\">PM_Acarix_Bokslutskommunik&eacute;_2020 sv<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/acarix-bokslutskommunike-q4-2020_final.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Fc77fe4ab-71c1-4fcd-b27d-f39b58cf815c\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/acarix-bokslutskommunike-q4-2020_final.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Fc77fe4ab-71c1-4fcd-b27d-f39b58cf815c&type=jpg\"><\/span>Acarix Bokslutskommunike Q4 2020_Final<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/pm_acarix_bokslutskommunike_2020-sv.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Ff88e5430-7ea2-4ba1-ae66-bba89f821649\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/pm_acarix_bokslutskommunike_2020-sv.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Ff88e5430-7ea2-4ba1-ae66-bba89f821649&type=jpg\"><\/span>PM_Acarix_Bokslutskommunik\u00e9_2020 sv<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Press release (MAR) Malm&ouml;, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik&eacute; 2020 Ett starkt avslut p&aring; ett h&auml;ndelserikt &aring;r<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[157,140,149,139,148,155,142,161],"tags":[],"class_list":["post-8325","post","type-post","status-publish","format-standard","hentry","category-mfn-report-interim","category-mfn-type-ir","category-mfn-regulatory-mar","category-mfn","category-mfn-regulatory","category-mfn-report","category-mfn-lang-sv","category-mfn-report-interim-q4"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix\" \/>\n<meta property=\"og:description\" content=\"Press release (MAR) Malm&ouml;, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik&eacute; 2020 Ett starkt avslut p&aring; ett h&auml;ndel\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-18T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T19:05:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/3287a1509d5d64a905690356084cb395\"},\"headline\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020\",\"datePublished\":\"2021-02-18T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:05:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/\"},\"wordCount\":1207,\"articleSection\":[\"Interim\",\"IR\",\"MAR\",\"News\",\"Regulatory\",\"Report\",\"Swedish\",\"Yearend\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/\",\"name\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2021-02-18T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:05:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/3287a1509d5d64a905690356084cb395\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/3287a1509d5d64a905690356084cb395\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","og_description":"Press release (MAR) Malm&ouml;, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik&eacute; 2020 Ett starkt avslut p&aring; ett h&auml;ndel","og_url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/","og_site_name":"Acarix","article_published_time":"2021-02-18T07:00:00+00:00","article_modified_time":"2024-11-18T19:05:42+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/3287a1509d5d64a905690356084cb395"},"headline":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020","datePublished":"2021-02-18T07:00:00+00:00","dateModified":"2024-11-18T19:05:42+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/"},"wordCount":1207,"articleSection":["Interim","IR","MAR","News","Regulatory","Report","Swedish","Yearend"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/","url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/","name":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2021-02-18T07:00:00+00:00","dateModified":"2024-11-18T19:05:42+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/3287a1509d5d64a905690356084cb395"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/3287a1509d5d64a905690356084cb395","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=8325"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8325\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=8325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=8325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=8325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}